These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 31114988)

  • 1. MicroRNA-132 reverses cisplatin resistance and metastasis in ovarian cancer by the targeted regulation on Bmi-1.
    Zhang XL; Sun BL; Tian SX; Li L; Zhao YC; Shi PP
    Eur Rev Med Pharmacol Sci; 2019 May; 23(9):3635-3644. PubMed ID: 31114988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-124 changes the sensitivity of lung cancer cells to cisplatin through targeting STAT3.
    Qi MM; Ge F; Chen XJ; Tang C; Ma J
    Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5242-5250. PubMed ID: 31298375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of circBIRC6 targeting miR-367-3p on cisplatin resistance of ovarian cancer cells].
    Zhang J; Bai HJ
    Zhonghua Zhong Liu Za Zhi; 2021 Oct; 43(10):1062-1068. PubMed ID: 34695896
    [No Abstract]   [Full Text] [Related]  

  • 4. [Expression of microRNA-100 and its correlation with drug resistance in human ovarian cancer SKOV3/DDP cells].
    Guo P; Peng D; Xiong X; Zhang S
    Nan Fang Yi Ke Da Xue Xue Bao; 2015 Nov; 35(11):1624-7. PubMed ID: 26607088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR‑210‑3p regulates cell growth and affects cisplatin sensitivity in human ovarian cancer cells via targeting E2F3.
    Jin Y; Wei J; Xu S; Guan F; Yin L; Zhu H
    Mol Med Rep; 2019 Jun; 19(6):4946-4954. PubMed ID: 30957179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect and mechanism of miR-217 on drug resistance, invasion and metastasis of ovarian cancer cells through a regulatory axis of CUL4B gene silencing/inhibited Wnt/β-catenin signaling pathway activation.
    Liu HR; Zhao J
    Eur Rev Med Pharmacol Sci; 2021 Jan; 25(1):94-107. PubMed ID: 33506897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long Non-coding RNA CCAT1 Sponges miR-454 to Promote Chemoresistance of Ovarian Cancer Cells to Cisplatin by Regulation of Surviving.
    Wang DY; Li N; Cui YL
    Cancer Res Treat; 2020 Jul; 52(3):798-814. PubMed ID: 32124583
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of microRNA-1271 on ovarian cancer via inhibition of epithelial-mesenchymal transition and cisplatin resistance.
    Chen Y; Wang L; Zhou J
    J Obstet Gynaecol Res; 2019 Nov; 45(11):2243-2254. PubMed ID: 31411791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of MTRR gene on apoptosis and autophagy pathways in multiresistant epithelial ovarian cancer].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Apr; 51(4):285-92. PubMed ID: 27116987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of microRNA-196a might reverse cisplatin resistance of A549/DDP non-small-cell lung cancer cell line.
    Li JH; Luo N; Zhong MZ; Xiao ZQ; Wang JX; Yao XY; Peng Y; Cao J
    Tumour Biol; 2016 Feb; 37(2):2387-94. PubMed ID: 26376998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biological effect of down-regulating of MTRR gene on cisplatin-resistant ovarian cancer SKOV3 cells in vitro and in vivo studies].
    Chen J; Wang Q; Zhang W; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2016 Feb; 51(2):126-34. PubMed ID: 26917482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-145 changes sensitivity of non-small cell lung cancer to gefitinib through targeting ADAM19.
    Wang Y; Lian YM; Ge CY
    Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5831-5839. PubMed ID: 31298334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-133b targets glutathione S-transferase π expression to increase ovarian cancer cell sensitivity to chemotherapy drugs.
    Chen S; Jiao JW; Sun KX; Zong ZH; Zhao Y
    Drug Des Devel Ther; 2015; 9():5225-35. PubMed ID: 26396496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exosomal miR-21-5p derived from cisplatin-resistant SKOV3 ovarian cancer cells promotes glycolysis and inhibits chemosensitivity of its progenitor SKOV3 cells by targeting PDHA1.
    Zhuang L; Zhang B; Liu X; Lin L; Wang L; Hong Z; Chen J
    Cell Biol Int; 2021 Oct; 45(10):2140-2149. PubMed ID: 34288231
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DDP-resistant ovarian cancer cells-derived exosomal microRNA-30a-5p reduces the resistance of ovarian cancer cells to DDP.
    Liu R; Zhang Y; Sun P; Wang C
    Open Biol; 2020 Apr; 10(4):190173. PubMed ID: 32343928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LncRNA KCNQ1OT1 contributes to the cisplatin resistance of tongue cancer through the KCNQ1OT1/miR-124-3p/TRIM14 axis.
    Qiao CY; Qiao TY; Jin H; Liu LL; Zheng MD; Wang ZL
    Eur Rev Med Pharmacol Sci; 2020 Jan; 24(1):200-212. PubMed ID: 31957833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Linc00161 regulated the drug resistance of ovarian cancer by sponging microRNA-128 and modulating MAPK1.
    Xu M; Zhou K; Wu Y; Wang L; Lu S
    Mol Carcinog; 2019 Apr; 58(4):577-587. PubMed ID: 30556928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recovery of miR-139-5p in Ovarian Cancer Reverses Cisplatin Resistance by Targeting C-Jun.
    Jiang Y; Jiang J; Jia H; Qiao Z; Zhang J
    Cell Physiol Biochem; 2018; 51(1):129-141. PubMed ID: 30439707
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MiR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine.
    Xiang Y; Ma N; Wang D; Zhang Y; Zhou J; Wu G; Zhao R; Huang H; Wang X; Qiao Y; Li F; Han D; Wang L; Zhang G; Gao X
    Oncogene; 2014 Jan; 33(3):378-86. PubMed ID: 23318422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect of miR-145 on Migration and Invasion of Ovarian Cancer Cells].
    Li J; Zhou YY; Zhao L; Li X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Oct; 41(5):581-588. PubMed ID: 31699186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.